NCT06741917View on ClinicalTrials.gov

Retrograde Intrarenal Surgery Low Risk Trial

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Retrograde Intrarenal SurgeryRenal Stones
Interventions
DRUG

Levofloxacin

single dose of oral Levofloxacin (500mg/tab) before retrograde intrarenal surgery

DRUG

Cefmetazole (drug)

single dose of intravenous Cefmetazole (1000 mg)before retrograde intrarenal surgery

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06741917 - Retrograde Intrarenal Surgery Low Risk Trial | Biotech Hunter | Biotech Hunter